Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3058813
Reference Type
Journal Article
Title
False-negative MR imaging of malignant breast tumors
Author(s)
Boetes, C; Strijk, SP; Holland, R; Barentsz, JO; Vandersluis, RF; Ruijs, JHJ
Year
1997
Is Peer Reviewed?
Yes
Journal
European Radiology
ISSN:
0938-7994
EISSN:
1432-1084
Volume
7
Issue
8
Page Numbers
1231-1234
PMID
9377507
DOI
10.1007/s003300050281
Web of Science Id
WOS:A1997XZ93100011
Abstract
In this study we analyze MR-negative malignant lesions of the breast. A total of 204 patients with palpable and/or mammographic lesions were studied. The MR technique consisted of the turbo FLASH and MP-RAGE subtraction techniques. All patients underwent surgical biopsy and/or mastectomy and all specimens were examined by the correlation radiologic-histologic mapping technique. A total of 208 lesions were evaluated; 145 turned out to be malignant and 63 proved to be benign. Six malignant lesions were misinterpreted as benign on MR imaging; thus, suspicious contrast enhancement was present in 96% of the lesions detected by mammography, US, or clinical examination. Especially 4 of the 17 ductal carcinoma in situ (DCIS) lesions were misinterpreted (23.5%). Despite optimal technique, 6 malignant lesions were not identified by MR imaging. The highest prevalence of these MR occult lesions was in th group of DCIS. Although MR imaging has an important role in the evaluation of breast lesions and, primarily, in ruling out malignancy, one should be aware of the fact that false-negative MR findings do occur.
Keywords
breast neoplasms; MR; contrast enhancement; gadolinium
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity